[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Drugs for Malaria Market Research by Company, Type & Application 2013-2025

April 2018 | 86 pages | ID: G0886C7B5C1EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Market Segment as follows:

By Type
  • Aryl Aminoalcohol Compounds
  • Antifolate Compounds
  • Artemisinin Compounds
By Application
  • Prevention
  • Treatment
  • Others
By Company
  • Guilin Pharmaceutical
  • Cipla
  • IPCA Laboratories
  • GlaxoSmithKline
  • Mylan Labs
  • Roche
  • Novartis
  • Sanofi Aventis
  • Ajanta Pharma
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 Aryl Aminoalcohol Compounds
    1.1.2.2 Antifolate Compounds
    1.1.2.3 Artemisinin Compounds
  1.1.3 Market by Application
    1.1.3.1 Prevention
    1.1.3.2 Treatment
    1.1.3.3 Others
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Guilin Pharmaceutical
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Cipla
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 IPCA Laboratories
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 GlaxoSmithKline
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Mylan Labs
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Roche
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Novartis
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Sanofi Aventis
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Ajanta Pharma
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Guilin Pharmaceutical
Table Sales Revenue, Volume, Price, Cost and Margin of Cipla
Table Sales Revenue, Volume, Price, Cost and Margin of IPCA Laboratories
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Mylan Labs
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi Aventis
Table Sales Revenue, Volume, Price, Cost and Margin of Ajanta Pharma

LIST OF FIGURES

Figure Aryl Aminoalcohol Compounds Market Size and CAGR 2013-2017 (Million USD)
Figure Aryl Aminoalcohol Compounds Market Size and CAGR 2013-2017 (Volume)
Figure Aryl Aminoalcohol Compounds Market Forecast and CAGR 2018-2025 (Million USD)
Figure Aryl Aminoalcohol Compounds Market Forecast and CAGR 2018-2025 (Volume)
Figure Antifolate Compounds Market Size and CAGR 2013-2017 (Million USD)
Figure Antifolate Compounds Market Size and CAGR 2013-2017 (Volume)
Figure Antifolate Compounds Market Forecast and CAGR 2018-2025 (Million USD)
Figure Antifolate Compounds Market Forecast and CAGR 2018-2025 (Volume)
Figure Artemisinin Compounds Market Size and CAGR 2013-2017 (Million USD)
Figure Artemisinin Compounds Market Size and CAGR 2013-2017 (Volume)
Figure Artemisinin Compounds Market Forecast and CAGR 2018-2025 (Million USD)
Figure Artemisinin Compounds Market Forecast and CAGR 2018-2025 (Volume)
Figure Prevention Market Size and CAGR 2013-2017 (Million USD)
Figure Prevention Market Size and CAGR 2013-2017 (Volume)
Figure Prevention Market Forecast and CAGR 2018-2025 (Million USD)
Figure Prevention Market Forecast and CAGR 2018-2025 (Volume)
Figure Treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Treatment Market Size and CAGR 2013-2017 (Volume)
Figure Treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Drugs for Malaria Market Size and CAGR 2013-2017 (Million USD)
Figure Global Drugs for Malaria Market Size and CAGR 2013-2017 (Volume)
Figure Global Drugs for Malaria Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Drugs for Malaria Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Drugs for Malaria Market Size and CAGR 2013-2017 (Million USD)
Figure United States Drugs for Malaria Market Size and CAGR 2013-2017 (Volume)
Figure United States Drugs for Malaria Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Drugs for Malaria Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Drugs for Malaria SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications